FAQ
1. Should I take antibiotics for a cold or flu?
No. Colds and flu are caused by viruses, and antibiotics only work against bacteria, so they won’t help and can contribute to resistance.
2. Does the use of antibiotics in animals affect human AMR?
Yes. Antibiotics used in animals, often similar to those used in humans, can select for resistant bacteria that may transfer to humans through direct contact or consumption of contaminated food and water.
3. What is antimicrobial stewardship?
Antimicrobial stewardship refers to coordinated efforts to optimize the use of antimicrobials to improve patient outcomes, reduce resistance, and decrease unnecessary costs.
4. What organizations are involved in addressing AMR globally?
Key organizations include the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Food and Agriculture Organization (FAO), and World Organization for Animal Health (OIE), among others.
Reference
1. Dadgostar, P. (2019). Antimicrobial resistance: implications and costs. Infection and drug resistance, 3903-3910.
2. Egorov, A. M., Ulyashova, M. M., & Rubtsova, M. Y. (2020). Inhibitors of β-lactamases. New life of β-lactam antibiotics. Biochemistry (Moscow), 85, 1292-1309.
3. Naziri, Z., Derakhshandeh, A., Soltani Borchaloee, A., et al. (2020). Treatment failure in urinary tract infections: a warning witness for virulent multi-drug resistant ESBL-producing Escherichia coli. Infection and drug resistance, 1839-1850.
4. Tängdén, T., & Giske, C. G. (2015). Global dissemination of extensively drug‐resistant carbapenemase‐producing E nterobacteriaceae: clinical perspectives on detection, treatment and infection control. Journal of internal medicine, 277(5), 501-512.
5. Grema, H. A., Geidam, Y. A., Gadzama, G. B., et al. (2015). Methicillin resistant Staphylococcus aureus (MRSA): a review.
6. Belay, W. Y., Getachew, M., Tegegne, B. A., et al. (2024). Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: A review. Frontiers in Pharmacology, 15, 1444781.
7. Vivekanandan, K. E., Kumar, P. V., Jaysree, R. C., et al. (2025). Exploring Molecular Mechanisms of Drug Resistance in Bacteria and Progressions in CRISPR/Cas9-Based Genome Expurgation Solutions. Global Medical Genetics, 100042.
8. Zhang, F., & Cheng, W. (2022). The mechanism of bacterial resistance and potential bacteriostatic strategies. Antibiotics, 11(9), 1215.
9. Murray, C. J., Ikuta, K. S., Sharara, F., et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The lancet, 399(10325), 629-655.
10. Bush, K., & Bradford, P. A. (2016). β-Lactams and β-lactamase inhibitors: an overview. Cold Spring Harbor perspectives in medicine, 6(8), a025247.
11. Golkar, Z., Bagasra, O., & Pace, D. G. (2014). Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. The Journal of Infection in Developing Countries, 8(02), 129-136.
12. Magana, M., Pushpanathan, M., Santos, A. L., et al. (2020). The value of antimicrobial peptides in the age of resistance. Lancet Infect Dis, 20, e216-30.
13. Wallis, R. S., O’Garra, A., Sher, A., et al. (2022). Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nature Reviews. Immunology, 23(2), 121.
14. Mayorga-Ramos, A., Zúñiga-Miranda, J., Carrera-Pacheco, S. E., et al. (2023). CRISPR-Cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance. ACS infectious diseases, 9(7), 1283-1302.
15. Mancuso, G., Trinchera, M., Midiri, A., et al. (2024). Novel antimicrobial approaches to combat bacterial biofilms associated with urinary tract infections. Antibiotics, 13(2), 154.
16. Mayorga-Martinez, C. C., Zhang, L., & Pumera, M. (2024). Chemical multiscale robotics for bacterial biofilm treatment. Chemical Society Reviews, 53(5), 2284-2299.
17. Gupta, V., & Datta, P. (2019). Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids. The Indian Journal of Medical Research, 149(2), 97.
18. Andrews, J. R., Baker, S., Marks, F., et al. (2019). Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. The Lancet Infectious Diseases, 19(1), e26-e30.
19. Tsalik, E. L., Petzold, E., Kreiswirth, B. N., et al. (2017). Advancing diagnostics to address antibacterial resistance: the Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases, 64(suppl_1), S41-S47.